Does a paclitaxel-coated balloon improve angiographic end points compared to a drug-eluting stent in patients undergoing PCI of small coronary vessels?
The Dior paclitaxel-coated balloon failed to demonstrate equivalence to the Taxus drug-eluting stent for angiographic endpoints in the treatment of small coronary arteries.
Dior PCB failed to show equivalence to Taxus DES regarding angiographic end points during PCI of small coronary arteries. CLINICAL TRIAL REGISTRATION NUMBER (EUDRACT CODE): 2009-012268-15.
Cortese et al. (Wed,) studied this question.